Pantoprazole prophylaxis in ICU patients with high severity of disease: a post hoc analysis of the placebo-controlled SUP-ICU trial.
Søren MarkerAnders PernerJørn WetterslevMette KragTheis LangeMatt P WiseMark BorthwickStepani BendelFrederik KeusAnne Berit GuttormsenJoerg C SchefoldMorten Hylander Møllernull nullPublished in: Intensive care medicine (2019)
In this post hoc analysis of patients with high disease severity included in the SUP-ICU trial, we observed higher 90-day mortality and fewer days alive without life support with pantoprazole vs placebo. Some of this may have been explained by missing SAPS II data, but further research is needed to draw firm conclusions. CLINICALTRIALS.GOV: ClinicalTrials.gov No. NCT02467621.